| 1 |
Prevalence of antimicrobial resistance in enteric Escherichia coli from domestic pets and assessment of associated risk markers using a generalized linear mixed model |
|
|
| Liliana R. Leite-Martins,Maria I.M. Mahú,Ana L. Costa,Ângelo Mendes,Elisabete Lopes,Denisa M.V. Mendonça,João J.R. Niza-Ribeiro,Augusto J.F. de Matos,Paulo Martins da Costa |
|
| Preventive Veterinary Medicine. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal |
|
|
| Ram Pokhrel,Badri Thapa,Rajesh Kafle,Pradeep Shah,Chanwit Tribuddharat |
|
| BMC Research Notes. 2014; 7(1): 694 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Antimicrobial activity of cefepime–tazobactam combination tested against clinical isolates of Enterobacteriaceae |
|
|
| Ramanpreet Kaur,Vikas Gautam,Lipika Singhal,Pallab Ray |
|
| The Journal of Antibiotics. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Surveillance of ESBL producing multidrug resistant Escherichia coli in a teaching hospital in India |
|
|
| Shakti Rath,Debasmita Dubey,Mahesh C. Sahu,Nagen K. Debata,Rabindra N. Padhy |
|
| Asian Pacific Journal of Tropical Disease. 2014; 4(2): 140 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Anti-ESBL activity of silver nanoparticles biosynthesized using soil Streptomyces species |
|
|
| Jasmine Subashini,V. Gopiesh Khanna,K. Kannabiran |
|
| Bioprocess and Biosystems Engineering. 2014; 37(6): 999 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Analyse rétrospective de l’antibiothérapie probabiliste des infections respiratoires basses chez des patients admis aux urgences du centre hospitalier Louis-Jaillon (Saint-Claude, France) |
|
|
| J.F. Carod,N. Floret,B. Draou,V. Daucourt,A. Sakho,E. Blanc,J.F. Faucher,J. Leroy |
|
| Journal Européen des Urgences et de Réanimation. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings |
|
|
| Mamoon A. Aldeyab,Stephan Harbarth,Nathalie Vernaz,Mary P. Kearney,Michael G. Scott,Feras W. Darwish Elhajji,Motasem A. Aldiab,James C. McElnay |
|
| British Journal of Clinical Pharmacology. 2012; 74(1): 171 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Development of antibiotics for Gram-negatives: where now? |
|
|
| Matteo Bassetti,Francesca Ginocchio,Daniele Roberto Giacobbe,Malgorzata Mikulska |
|
| Clinical Investigation. 2011; 1(2): 211 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Will new antimicrobials overcome resistance among Gram-negatives? |
|
|
| Matteo Bassetti,Francesca Ginocchio,Malgorzata Mikulska,Lucia Taramasso,Daniele Roberto Giacobbe |
|
| Expert Review of Anti-infective Therapy. 2011; 9(10): 909 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
